SCHEMBL22019757

SCHEMBL22019757

Cc1nc2c(c(C)c1-c1ccccc1)CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.50
MAPT P10636 8/20 0.50
MAPK1 P28482 2/20 0.50
LMNA P02545 1/20 0.50
ALDH1A1 P00352 7/20 0.49
HPGD P15428 5/20 0.49
NPSR1 Q6W5P4 5/20 0.49
HSD17B10 Q99714 4/20 0.49
FPR1 P21462 1/20 0.49
TSHR P16473 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
ADORA2A P29274 1/20 0.48
GAA P10253 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22019978 0.84 ACHE (0.54) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL24977965 0.81 MAPK1 (0.49) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL22019781 0.81 KDM4E (0.51) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL24977998 0.81 KDM4E (0.46) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL22019724 0.80 MAPK1 (0.54) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL28151465 0.75 KDM4E (0.50) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL30657668 0.73 HSD17B10 (0.58) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL12442826 0.72 BCHE (0.65) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL13277920 0.72 MAPT (0.47) KDM4EMAPTMAPK1LMNAALDH1A1
SCHEMBL13169612 0.72 BCHE (0.50) KDM4EMAPTMAPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed